New to this stock and just doing some research. In the short term afamelanotide looks to be aimed at some acute disorders which are extremely rare. Is this a profitable market? Are they really looking at the cosmetic market? If the latter I imagine theres a few more regulatory hurdles to go post therapeutic approval?
Can anyone comment?
New to this stock and just doing some research. In the short...
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.53 |
Change
0.290(1.90%) |
Mkt cap ! $777.7M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.55 | $15.03 | $861.9K | 56.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 164 | $15.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.53 | 512 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |